PD-1免疫治疗-话题@MedSci

#PD-1免疫治疗#

10篇内容 | 1546人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2182503, encodeId=b754218250371, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=e6924180936' target=_blank style='color:#2F92EE;'>#基因突变#</a> <a href='/topic/show?id=33da1390303' target=_blank style='color:#2F92EE;'>#PD-1免疫治疗#</a>, objectTitle=PD-1免疫治疗效果冰火两重天，可能是这些基因发生突变了！, objectType=article, longId=809251, objectId=7deb80925110, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-staff-meeting-GXNVP9J.jpg, objectUrl=/article/show_article.do?id=7deb80925110, replyNumber=0, likeNumber=75, createdTime=2024-01-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=7deb80925110, moduleTitle=PD-1免疫治疗效果冰火两重天，可能是这些基因发生突变了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7deb80925110)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1368008, encodeId=06271368008ad, content=<a href='/topic/show?id=33da1390303' target=_blank style='color:#2F92EE;'>#PD-1免疫治疗#</a>, objectTitle=NEJM：PD-1免疫治疗使14例晚期直肠癌肿瘤完全消失, objectType=article, longId=728995, objectId=8c55e2899542, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c55e2899542, replyNumber=0, likeNumber=90, createdTime=2022-06-11, rootId=0, userName=dinorsor524, userId=e524260, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c55e2899542, moduleTitle=NEJM：PD-1免疫治疗使14例晚期直肠癌肿瘤完全消失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c55e2899542)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368007, encodeId=4e30136800e41, content=<a href='/topic/show?id=33da1390303' target=_blank style='color:#2F92EE;'>#PD-1免疫治疗#</a>, objectTitle=Clin Trans Gastroenterology：抗PD-1免疫治疗在有与无乙型肝炎病毒感染的结直肠癌患者中疗效比较, objectType=article, longId=728102, objectId=0854e2810284, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0854e2810284, replyNumber=0, likeNumber=98, createdTime=2022-05-30, rootId=0, userName=dinorsor524, userId=e524260, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0854e2810284, moduleTitle=Clin Trans Gastroenterology：抗PD-1免疫治疗在有与无乙型肝炎病毒感染的结直肠癌患者中疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0854e2810284)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368006, encodeId=c8c9136800681, content=<a href='/topic/show?id=33da1390303' target=_blank style='color:#2F92EE;'>#PD-1免疫治疗#</a>, objectTitle=AACR重磅之SPOTLIGHT203试验：瘤内注射BO-112联合帕博丽珠单抗对PD-1免疫治疗耐药的晚期黑色素瘤患者的疗效, objectType=article, longId=723987, objectId=2fc5e239870d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fc5e239870d, replyNumber=0, likeNumber=110, createdTime=2022-04-12, rootId=0, userName=dinorsor524, userId=e524260, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fc5e239870d, moduleTitle=AACR重磅之SPOTLIGHT203试验：瘤内注射BO-112联合帕博丽珠单抗对PD-1免疫治疗耐药的晚期黑色素瘤患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fc5e239870d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368005, encodeId=abcf136800551, content=<a href='/topic/show?id=33da1390303' target=_blank style='color:#2F92EE;'>#PD-1免疫治疗#</a>, objectTitle=PD-1免疫治疗药物拓益®尿路上皮癌适应症在中国获批, objectType=article, longId=209983, objectId=86f62099835f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86f62099835f, replyNumber=0, likeNumber=91, createdTime=2021-04-16, rootId=0, userName=dinorsor524, userId=e524260, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86f62099835f, moduleTitle=PD-1免疫治疗药物拓益®尿路上皮癌适应症在中国获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86f62099835f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368004, encodeId=d6151368004a2, content=<a href='/topic/show?id=33da1390303' target=_blank style='color:#2F92EE;'>#PD-1免疫治疗#</a>, objectTitle=J Immunother Cancer：晚期黑色素瘤抗PD-1免疫治疗时的耐药类型和影像学变化, objectType=article, longId=207791, objectId=3b0c20e7910a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b0c20e7910a, replyNumber=0, likeNumber=104, createdTime=2021-03-03, rootId=0, userName=dinorsor524, userId=e524260, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b0c20e7910a, moduleTitle=J Immunother Cancer：晚期黑色素瘤抗PD-1免疫治疗时的耐药类型和影像学变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b0c20e7910a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368003, encodeId=aef6136800365, content=<a href='/topic/show?id=33da1390303' target=_blank style='color:#2F92EE;'>#PD-1免疫治疗#</a>, objectTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, objectType=article, longId=205718, objectId=9075205e18ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9075205e18ad, replyNumber=0, likeNumber=97, createdTime=2021-01-15, rootId=0, userName=dinorsor524, userId=e524260, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9075205e18ad, moduleTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9075205e18ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368002, encodeId=35e11368002b5, content=<a href='/topic/show?id=33da1390303' target=_blank style='color:#2F92EE;'>#PD-1免疫治疗#</a>, objectTitle=CELL：TREM2可增强肿瘤抗PD-1免疫治疗效果 , objectType=article, longId=199294, objectId=7bfe199294c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bfe199294c1, replyNumber=0, likeNumber=99, createdTime=2020-08-14, rootId=0, userName=dinorsor524, userId=e524260, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bfe199294c1, moduleTitle=CELL：TREM2可增强肿瘤抗PD-1免疫治疗效果 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bfe199294c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368001, encodeId=12d8136800188, content=<a href='/topic/show?id=33da1390303' target=_blank style='color:#2F92EE;'>#PD-1免疫治疗#</a>, objectTitle=[CSCO2017巅峰对话] Charles Balch ＆廖宁：乳腺癌PD-1免疫治疗新进展, objectType=article, longId=116921, objectId=ba1d11692190, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba1d11692190, replyNumber=0, likeNumber=63, createdTime=2017-10-22, rootId=0, userName=dinorsor524, userId=e524260, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba1d11692190, moduleTitle=[CSCO2017巅峰对话] Charles Balch ＆廖宁：乳腺癌PD-1免疫治疗新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba1d11692190)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368000, encodeId=97c8136800017, content=<a href='/topic/show?id=33da1390303' target=_blank style='color:#2F92EE;'>#PD-1免疫治疗#</a>, objectTitle=CLIN CANCER RES：肺癌TP53及KRAS突变预测阻断PD-1免疫治疗反应, objectType=article, longId=104354, objectId=cb2b10435459, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb2b10435459, replyNumber=0, likeNumber=89, createdTime=2017-07-04, rootId=0, userName=dinorsor524, userId=e524260, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb2b10435459, moduleTitle=CLIN CANCER RES：肺癌TP53及KRAS突变预测阻断PD-1免疫治疗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb2b10435459)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367999, encodeId=1293136e99981, content=<a href='/topic/show?id=33da1390303' target=_blank style='color:#2F92EE;'>#PD-1免疫治疗#</a>, objectTitle=Lancet Oncol：PD-1免疫治疗药物能有效治疗恶性胸膜间皮瘤 (KEYNOTE-028), objectType=article, longId=94466, objectId=d9bf94466c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9bf94466c1, replyNumber=0, likeNumber=75, createdTime=2017-04-04, rootId=0, userName=dinorsor524, userId=e524260, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9bf94466c1, moduleTitle=Lancet Oncol：PD-1免疫治疗药物能有效治疗恶性胸膜间皮瘤 (KEYNOTE-028), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9bf94466c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PD-1免疫治疗

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肺癌# #基因突变# #PD-1免疫治疗#

PD-1免疫治疗效果冰火两重天，可能是这些基因发生突变了！

2024-01-18发表于陕西省

dinorsor524 (审核中...)

前往app查看评论内容

#PD-1免疫治疗#

NEJM：PD-1免疫治疗使14例晚期直肠癌肿瘤完全消失

2022-06-11

dinorsor524 (审核中...)

前往app查看评论内容

#PD-1免疫治疗#

Clin Trans Gastroenterology：抗PD-1免疫治疗在有与无乙型肝炎病毒感染的结直肠癌患者中疗效比较

2022-05-30

dinorsor524 (审核中...)

前往app查看评论内容

#PD-1免疫治疗#

AACR重磅之SPOTLIGHT203试验：瘤内注射BO-112联合帕博丽珠单抗对PD-1免疫治疗耐药的晚期黑色素瘤患者的疗效

2022-04-12

dinorsor524 (审核中...)

前往app查看评论内容

#PD-1免疫治疗#

PD-1免疫治疗药物拓益®尿路上皮癌适应症在中国获批

2021-04-16

dinorsor524 (审核中...)

前往app查看评论内容

#PD-1免疫治疗#

J Immunother Cancer：晚期黑色素瘤抗PD-1免疫治疗时的耐药类型和影像学变化

2021-03-03

dinorsor524 (审核中...)

前往app查看评论内容

#PD-1免疫治疗#

J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效

2021-01-15

dinorsor524 (审核中...)

前往app查看评论内容

#PD-1免疫治疗#

CELL：TREM2可增强肿瘤抗PD-1免疫治疗效果

2020-08-14

dinorsor524 (审核中...)

前往app查看评论内容

#PD-1免疫治疗#

[CSCO2017巅峰对话] Charles Balch ＆廖宁：乳腺癌PD-1免疫治疗新进展

2017-10-22

dinorsor524 (审核中...)

前往app查看评论内容

#PD-1免疫治疗#

CLIN CANCER RES：肺癌TP53及KRAS突变预测阻断PD-1免疫治疗反应

2017-07-04

dinorsor524 (审核中...)

前往app查看评论内容

#PD-1免疫治疗#

Lancet Oncol：PD-1免疫治疗药物能有效治疗恶性胸膜间皮瘤 (KEYNOTE-028)

2017-04-04

科室
- - 订阅+
  - 更多科室
工具
服务